共查询到19条相似文献,搜索用时 93 毫秒
1.
2.
麦角硫因(ergothioneine,ERG)是存在于自然界的一种含硫氨基酸,因其具有较强的清除自由基和抗衰老能力且天然安全无毒,近年来在食品、医药、化妆品等领域广泛应用。麦角硫因作为一种天然高效的抗氧化剂,在与氧化应激相关的疾病预防和治疗中发挥着重要的作用。本文综述了麦角硫因的结构与性质、抗氧化特性,干预氧化应激相关疾病的作用与机制等研究进展,为麦角硫因多元应用提供参考。 相似文献
3.
一种稀有的天然氨基酸-麦角硫因 总被引:2,自引:0,他引:2
麦角硫因是自然界中一种稀有天然氨基酸,在机体内具有重要的生理活性,国外研究表明其具有较强的抗氧化作用,目前国内相关报道很少。文章对麦角硫因的理化特性、在自然界中的分布、生物学功能、代谢过程及其分离纯化方法作了简单介绍,并展望了麦角硫因的应用前景。 相似文献
4.
麦角碱生物合成途径中酶学及相关基因研究进展 总被引:1,自引:0,他引:1
简要介绍了麦角碱(ergot alkaloids)的化学、药理学及生物合成方面的相关知识.综述了近年来麦角碱生物合成途径中酶学和相关基因方面的研究进展以及它对麦角碱生产的影响,探讨了麦角碱生物合成途径方面的研究方向和发展前景。 相似文献
5.
微生物麦角固醇的研究进展 总被引:17,自引:0,他引:17
麦角固醇是真菌细胞膜的重要组成成分,它在确保膜结构的完整性、与膜结合酶的活性、膜的流动性、细胞活力以及物质运输等方面起着重要作用。麦角固醇生物合成途径中的几个关键环节还是抗真菌药物的作用靶位,对其生物合成的研究将为抗真菌药物的筛选及其作用机制的研究提供重要的理论基础川。麦角固醇经UV照射可转化为维生素VDZ,VDZ是一种重要的药品.自从Taret首次从麦角中分离得到麦角固醇以来,随后便开展了对其来源、性质、分离、测定、高产株的选育及其发酵条件等的研究[‘-‘]。近年来一些研究者对麦角固醇生物合成途径进行… 相似文献
6.
二硫吡咯酮类抗生素是一类具有独特的吡咯酮二硫杂环戊二烯(4H-[1,2]二硫[4,3-b]吡咯-5-酮)骨架的化合物的总称。基于N-7位酰基侧链的不同以及N-4位是否含有甲基,可分为N-methyl-Nacylpyrrothine、N-acylpyrrothine和thiomarinols等类别。迄今为止,已有27种该类化合物被报道,重要代表包括全霉素(holomycin)、硫藤黄菌素(thiolutin)、金霉素(aureothricin)以及最近发现的thiomarinols。就生物活性而言,二硫吡咯酮类抗生素具有广谱的抗细菌活性,对多种微生物,包括革兰氏阴性菌、革兰氏阳性菌以及寄生虫都有较好的杀灭活性。甚至一些二硫吡咯酮衍生物表现出较强的抗肿瘤活性。近几年来,多个二硫吡咯酮类抗生素的生物合成基因簇相继被报道,其生物合成机理也逐步被阐明。本文将针对目前国内外二硫吡咯酮类抗生素的生物合成研究进展,以及在组合生物合成与代谢工程领域所取得的成果进行综述,旨在为通过合成生物学的方法创造结构新颖、高效低毒的"非天然"二硫吡咯酮类化合物提供理论借鉴。 相似文献
7.
《中国科学:生命科学》2017,(5)
天然产物尤其是次级代谢产物在药物化学和化学生物学中扮演重要角色.基于天然产物获得结构多样性的类似物对于新药的筛选和医学研究具有重要意义.天然产物均由生物体代谢产生,在了解其生物合成机制的基础上,对生物合成过程进行合理化改造,可以极大地丰富天然产物的结构多样性,获得许多具有重要生理活性和有机化学不易合成的天然产物类似物.本文以硫肽类抗生素中的硫链丝菌素和聚酮聚肽类化合物为例,对生物合成方法在天然产物结构多样性中的应用进行总结和展望. 相似文献
8.
9.
10.
羊毛硫肽(lanthipeptide)是由核糖体合成并经翻译后修饰产生的肽类天然产物,具有丰富的分子结构和多样的生物活性.新型羊毛硫肽是活性药物的重要来源,可以通过基因组挖掘和工程改造获得.羊毛硫肽前体肽由基因编码,同时其合成酶具有较高的底物杂泛性.基于这些特征,可以对羊毛硫肽的生物合成过程开展高通量工程改造,从而快速... 相似文献
11.
Ergothioneine (ERG) is an unusual sulfur-containing amino acid. It is a potent antioxidant, which shows great potential for ameliorating neurodegenerative and cardiovascular diseases. L-ergothioneine is rare in nature, with mushrooms being the primary dietary source. The chemical synthesis process is complex and expensive. Alternatively, ERG can be produced by fermentation of recombinant microorganisms engineered for ERG overproduction. Here, we describe the engineering of S. cerevisiae for high-level ergothioneine production on minimal medium with glucose as the only carbon source. To this end, metabolic engineering targets in different layers of the amino acid metabolism were selected based on literature and tested. Out of 28 targets, nine were found to improve ERG production significantly by 10%–51%. These targets were then sequentially implemented to generate an ergothioneine-overproducing yeast strain capable of producing 106.2 ± 2.6 mg/L ERG in small-scale cultivations. Transporter engineering identified that the native Aqr1 transporter was capable of increasing the ERG production in a yeast strain with two copies of the ERG biosynthesis pathway, but not in the strain that was further engineered for improved precursor supply. Medium optimization indicated that additional supplementation of pantothenate improved the strain's productivity further and that no supplementation of amino acid precursors was necessary. Finally, the engineered strain produced 2.39 ± 0.08 g/L ERG in 160 h (productivity of 14.95 ± 0.49 mg/L/h) in a controlled fed-batch fermentation without supplementation of amino acids. This study paves the way for the low-cost fermentation-based production of ergothioneine. 相似文献
12.
Ergothioneine is a small, sulfur-containing metabolite (229 Da) synthesized by various species of bacteria and fungi, which can accumulate to millimolar levels in tissues or cells (e.g. erythrocytes) of higher eukaryotes. It is commonly marketed as a dietary supplement due to its proposed protective and antioxidative functions. In this study we report the genes forming the two-step ergothioneine biosynthetic pathway in the fission yeast, Schizosaccharomyces pombe. We identified the first gene, egt1+ (SPBC1604.01), by sequence homology to previously published genes from Neurospora crassa and Mycobacterium smegmatis. We showed, using metabolomic analysis, that the Δegt1 deletion mutant completely lacked ergothioneine and its precursors (trimethyl histidine/hercynine and hercynylcysteine sulfoxide). Since the second step of ergothioneine biosynthesis has not been characterized in eukaryotes, we examined four putative homologs (Nfs1/SPBC21D10.11c, SPAC11D3.10, SPCC777.03c, and SPBC660.12c) of the corresponding mycobacterial enzyme EgtE. Among deletion mutants of these genes, only one (ΔSPBC660.12c, designated Δegt2) showed a substantial decrease in ergothioneine, accompanied by accumulation of its immediate precursor, hercynylcysteine sulfoxide. Ergothioneine-deficient strains exhibited no phenotypic defects during vegetative growth or quiescence. To effectively study the role of ergothioneine, we constructed an egt1+ overexpression system by replacing its native promoter with the nmt1+ promoter, which is inducible in the absence of thiamine. We employed three versions of the nmt1 promoter with increasing strength of expression and confirmed corresponding accumulations of ergothioneine. We quantified the intracellular concentration of ergothioneine in S. pombe (0.3, 157.4, 41.6, and up to 1606.3 µM in vegetative, nitrogen-starved, glucose-starved, and egt1+-overexpressing cells, respectively) and described its gradual accumulation under long-term quiescence. Finally, we demonstrated that the ergothioneine pathway can also synthesize selenoneine, a selenium-containing derivative of ergothioneine, when the culture medium is supplemented with selenium. We further found that selenoneine biosynthesis involves a novel intermediate compound, hercynylselenocysteine. 相似文献
13.
Utilization of Candida glabrata overproducing pyruvate is a promising strategy for high-level acetoin production. Based on the known regulatory and metabolic information, acetaldehyde and thiamine were fed to identify the key nodes of carboligase activity reaction (CAR) pathway and provide a direction for engineering C. glabrata. Accordingly, alcohol dehydrogenase, acetaldehyde dehydrogenase, pyruvate decarboxylase, and butanediol dehydrogenase were selected to be manipulated for strengthening the CAR pathway. Following the rational metabolic engineering, the engineered strain exhibited increased acetoin biosynthesis (2.24 g/L). In addition, through in silico simulation and redox balance analysis, NADH was identified as the key factor restricting higher acetoin production. Correspondingly, after introduction of NADH oxidase, the final acetoin production was further increased to 7.33 g/L. By combining the rational metabolic engineering and cofactor engineering, the acetoin-producing C. glabrata was improved stepwise, opening a novel pathway for rational development of microorganisms for bioproduction. 相似文献
14.
甜菜碱提高植物抗盐性的作用机理及其遗传工程研究进展 总被引:3,自引:3,他引:0
系统地讨论了甜菜碱在提高植物抗盐性中的作用机理及其国内外研究进展,并对甜菜碱生物合成过程中关键酶及其遗传工程的研究进展进行了综述。提出在进一步弄清甜菜碱提高植物抗盐性作用机理的基础上,应在重要作物中开展甜菜碱合成相关基因的导入,以期获得耐盐植物新品种。 相似文献
15.
16.
紫杉醇生物合成途径及调控研究进展 总被引:8,自引:0,他引:8
本文综述了紫杉醇的生物合成途径、代谢调控及基因工程方面的研究进展,总结了代谢调控与基因工程方法提高红豆杉属植物细胞培养紫杉醇合成量的研究状况,并在探讨生物合成途径理论的基础上,对紫杉醇生物合成的限速步骤进行了阐述,指出解决侧链合成的根速步骤问题会显著提高紫杉醇的生物合成量。 相似文献
17.
人参皂苷生物合成和次生代谢工程 总被引:9,自引:0,他引:9
人参皂苷属于植物三萜皂苷类化合物,是传统名贵药材人参和西洋参的主要活性成分,具有抗炎、抗氧化作用,还有广泛的抗肿瘤作用。人参皂苷与植物甾醇共享前期代谢途径,通过2, 3-氧化鲨烯环化步骤进入三萜代谢分支途径,在三萜碳环骨架复杂修饰的基础上形成人参皂苷。综述了近年人参皂苷生物合成途径及关键酶基因研究的最新进展,揭示了人参皂苷生物合成的基本途径,对途径中关键酶的基因进行了综述,并结合次生代谢工程技术, 探讨了该技术在人参皂苷生物合成中的应用前景。 相似文献
18.
19.
植物中存在芪类次生代谢产物(stilbenes)作为一种重要的植保素,不仅能够使植物体本身的抗逆性提高,在人类健康医疗领域也有很好的应用前景.由于其合成途径具有专一性,需要芪合酶(Stilbene synthase,STS)的存在,近年来芪合酶基因工程日益引起人们的研究和重视.介绍了芪合酶基因的结构功能及其诱导表达的调控机理,并对其转基因工程的研究进展进行了综述,以期为进一步开展芪类次生代谢物在作物品质改良及人类健康营养中的应用提供参考. 相似文献